154 related articles for article (PubMed ID: 24682930)
1. Imaging findings of primary malignant gastrointestinal stromal tumor of the liver.
Kim HO; Kim JE; Bae KS; Choi BH; Jeong CY; Lee JS
Jpn J Radiol; 2014 Jun; 32(6):365-70. PubMed ID: 24682930
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
3. ¹⁸F-FDG PET/CT and contrast enhanced CT in differential diagnosis between leiomyoma and gastrointestinal stromal tumor.
Hirose Y; Kaida H; Kawahara A; Kurata S; Ishibashi M; Abe T
Hell J Nucl Med; 2015; 18(3):257-60. PubMed ID: 26574696
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH
J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2).
Nakashima T; Takayama Y; Nishie A; Asayama Y; Baba S; Yamashita Y; Shirabe K; Kubo Y; Hida T; Honda H
Clin Imaging; 2014; 38(6):888-91. PubMed ID: 25034402
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy.
Schmidt GP; Paprottka P; Jakobs TF; Hoffmann RT; Baur-Melnyk A; Haug A; Notohamiprodjo M; Baur-Melnyk A; Nikolaou K; Reiser MF; Rist C
Eur J Radiol; 2012 Mar; 81(3):e269-76. PubMed ID: 21398060
[TBL] [Abstract][Full Text] [Related]
8. Gastric Schwannoma mimicking malignant gastrointestinal stromal tumor and misdiagnosed by (18)F-FDG PET/CT.
Zhang Y; Li B; Cai L; Hou X; Shi H; Hou J
Hell J Nucl Med; 2015; 18(1):74-6. PubMed ID: 25840576
[TBL] [Abstract][Full Text] [Related]
9. Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Ahn SY; Lee JM; Joo I; Lee ES; Lee SJ; Cheon GJ; Han JK; Choi BI
Abdom Imaging; 2015 Apr; 40(4):843-51. PubMed ID: 25253426
[TBL] [Abstract][Full Text] [Related]
10. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG PET, CT, and MRI for detecting the malignant potential in patients with gastrointestinal stromal tumors: A protocol for a network meta-analysis of diagnostic test accuracy.
Wei K; Pan B; Yang H; Lu C; Ge L; Cao N
Medicine (Baltimore); 2018 Apr; 97(16):e0389. PubMed ID: 29668594
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory pseudotumor of the liver diagnosed as metastatic liver tumor in a patient with a gastrointestinal stromal tumor of the rectum: report of a case.
Matsuo Y; Sato M; Shibata T; Morimoto M; Tsuboi K; Shamoto T; Hirokawa T; Sato T; Takahashi H; Takeyama H
World J Surg Oncol; 2014 May; 12():140. PubMed ID: 24886578
[TBL] [Abstract][Full Text] [Related]
13. Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT.
Yoon JH; Lee JM; Chang W; Kang HJ; Bandos A; Lim HJ; Kang SY; Kang KW; Ryoo SB; Jeong SY; Park KJ
Radiology; 2020 Feb; 294(2):310-319. PubMed ID: 31793850
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
[TBL] [Abstract][Full Text] [Related]
15. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Kim SJ; Lee SW
J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory myofibroblastic tumours of the liver: gadoxetic acid-enhanced and diffusion-weighted MRI findings with 18F-FDG PET/CT and clinical significance of regression on follow-up.
Kang TW; Kim SH; Jang KM; Choi D; Choi JY; Park CK
Clin Radiol; 2014 May; 69(5):509-18. PubMed ID: 24581965
[TBL] [Abstract][Full Text] [Related]
17. Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors.
Winant AJ; Gollub MJ; Shia J; Antonescu C; Bains MS; Levine MS
AJR Am J Roentgenol; 2014 Aug; 203(2):306-14. PubMed ID: 25055264
[TBL] [Abstract][Full Text] [Related]
18. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
Mainenti PP; Mancini M; Mainolfi C; Camera L; Maurea S; Manchia A; Tanga M; Persico F; Addeo P; D'Antonio D; Speranza A; Bucci L; Persico G; Pace L; Salvatore M
Abdom Imaging; 2010 Oct; 35(5):511-21. PubMed ID: 19562412
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case.
Sumiyoshi T; Moriguchi M; Kanemoto H; Asakura K; Sasaki K; Sugiura T; Mizuno T; Uesaka K
Surg Today; 2012 Jan; 42(2):200-4. PubMed ID: 22160355
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases.
Surasi DS; O'Malley JP; Bhambhvani P
J Nucl Med Technol; 2015 Sep; 43(3):229-30. PubMed ID: 25655342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
